First Successful ADVOS User Conference
11.05. 2023 – 12.05.2023 Munich – ADVOS user conference at Schloss Hohenkammer brings together medical professionals from numerous clinics for the first time to share
Press Releases of ADVITOS GmbH
For journalists, a precise overview and up-to-date news are essential for their daily work. Our press area offers you information on what is happening around ADVITOS and an overview of press releases on our current topics. Find out about current developments here and use the direct contact to your contacts in our company.
ADVITOS participated in the Scaling Impact Executive Programme (SIEP)
20.06.2022 – 25.06.2022 We had the privilege of participating in the Scaling Impact Executive Education Programme at Católica Lisbon School of Business and Economics. Together
A Future-Oriented Reorganisation: New Drive for Medical Technology Innovation
01.06.2022 Munich – ADVITOS GmbH appoints new CEO and reveals future plans for growth ADVITOS GmbH is well-known for its breakthrough innovation in the medical
Personnel Boost in Effective Multi-Organ Support
27.01.2022 Munich – ADVITOS grows by new competences and capacities in three positions ADVITOS enjoys a well-earned reputation in the field of medical technology on
ADVITOS is one of the 15 finalists of the Social Innovation Tournament 2021
04.10.2021 On 7 October, we are one of the 15 finalists taking the stage in Lisbon to pitch our project for a chance to win
Catherine Schreiber (ADVITOS GmbH) among the recipients of the LaMonachia 2021 business award
13.07.2021 Munich – The city of Munich has awarded the “LaMonachia” prize for the third time. The business award for women honors successful female managers
Social Innovation Tournament 2021: ADVITOS GmbH among the 15 best social enterprises in Europe
14.05.2021 Munich – ADVITOS GmbH has been selected by the EIB Institute as one of the 15 best social entrepreneurs out of 280 applicants from
ADVITOS takes 1st place at the Innovation Award Bavaria 2020
24.11.2020 Munich – The Munich-based medical technology company was selected from 189 nominations by an independent jury and won the 1st main prize The Bavarian
ADVITOS receives EIC Accelerator funding to enhance therapy options for Corona Patients with severe organ dysfunction
30.06.2020 Munich – ADVITOS, which received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 880349, is one of
ADVITOS receives EIC Accelerator funding to enhance therapy options for Corona Patients with severe organ dysfunction
30.06.2020 Munich – ADVITOS, which received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 880349, is one of